Header Logo

Connection

KENNETH LIAO to Retrospective Studies

Back to Details
This is a "connection" page, showing publications KENNETH LIAO has written about Retrospective Studies.
KENNETH LIAO
Connection Strength
0.601
Retrospective Studies
  1. Does Gastrointestinal Bleeding Increase the Risk of Thromboembolic Events in Patients Supported With CF-LVADs? Artif Organs. 2026 Jun; 50(6):886-890.
    View in: PubMed
    Score: 0.066
  2. Driveline Infections Among Patients Supported With Left Ventricular Assist Devices: A Single Center Sixteen-Year Longitudinal Profile. Artif Organs. 2026 Apr; 50(4):572-579.
    View in: PubMed
    Score: 0.065
  3. Minimally Invasive Mitral Valve Surgery Using a Cold Fibrillatory Cardiac Arrest Technique in Patients With Prior Cardiac Surgery. Tex Heart Inst J. 2024 07 19; 51(2).
    View in: PubMed
    Score: 0.059
  4. NADPH oxidase overexpression and mitochondrial OxPhos impairment are more profound in human hearts donated after circulatory death than brain death. Am J Physiol Heart Circ Physiol. 2024 03 01; 326(3):H548-H562.
    View in: PubMed
    Score: 0.057
  5. Sex Disparities in Left Ventricular Assist Device Implantation: Delayed Presentation and Worse Right Heart Failure. ASAIO J. 2024 06 01; 70(6):469-476.
    View in: PubMed
    Score: 0.057
  6. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices. Semin Thorac Cardiovasc Surg. 2016 Summer; 28(2):363-375.
    View in: PubMed
    Score: 0.034
  7. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2013 Feb; 145(2):575-81.
    View in: PubMed
    Score: 0.027
  8. Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices. Ann Thorac Surg. 2011 Nov; 92(5):1593-9; discussion 1599-600.
    View in: PubMed
    Score: 0.025
  9. Basal cell carcinoma risk prediction in survivors of childhood cancer. J Natl Cancer Inst. 2025 Nov 01; 117(11):2352-2361.
    View in: PubMed
    Score: 0.016
  10. Effect of Preoperative Mitral Regurgitation on LVAD Outcomes in Patients with Elevated Pulmonary Vascular Resistance. Cardiovasc Drugs Ther. 2025 10; 39(5):1085-1095.
    View in: PubMed
    Score: 0.015
  11. Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND Trial. JACC Heart Fail. 2024 03; 12(3):438-447.
    View in: PubMed
    Score: 0.014
  12. Clinical Predictors and Outcomes After Left Ventricular Assist Device Implantation and Tracheostomy. Tex Heart Inst J. 2023 08 22; 50(4).
    View in: PubMed
    Score: 0.014
  13. The Use of Unilateral Erector Spinae Plane Block in Minimally Invasive Cardiac Surgery. J Cardiothorac Vasc Anesth. 2023 03; 37(3):432-436.
    View in: PubMed
    Score: 0.013
  14. Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs. 2023 Dec; 26(4):275-286.
    View in: PubMed
    Score: 0.013
  15. Distinctive kidney function trajectories following left ventricular assist device implantation. J Heart Lung Transplant. 2022 12; 41(12):1798-1807.
    View in: PubMed
    Score: 0.013
  16. Commentary: Guidance during uncertain times: Navigating the HeartWare HVAD recall. J Thorac Cardiovasc Surg. 2022 06; 163(6):2129-2130.
    View in: PubMed
    Score: 0.012
  17. Identifying Causative Microorganisms in Left Ventricular Assist Device Infections as a Guide for Developing Bacteriophage Therapy. J Surg Res. 2022 03; 271:73-81.
    View in: PubMed
    Score: 0.012
  18. Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs. 2022 Mar; 25(1):16-23.
    View in: PubMed
    Score: 0.012
  19. Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices. J Artif Organs. 2021 Jun; 24(2):207-216.
    View in: PubMed
    Score: 0.012
  20. Impact of 30 Day Readmission After Left Ventricular Assist Device Implantation. ASAIO J. 2019 Mar/Apr; 65(3):252-256.
    View in: PubMed
    Score: 0.010
  21. Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2017 Nov; 104(5):1556-1562.
    View in: PubMed
    Score: 0.009
  22. Gastrointestinal Bleeding during Continuous-Flow Left Ventricular Assist Device Support is Associated with Lower Rates of Cardiac Transplantation. ASAIO J. 2015 Nov-Dec; 61(6):635-9.
    View in: PubMed
    Score: 0.008
  23. Stroke After Left Ventricular Assist Device Implantation: Outcomes in the Continuous-Flow Era. Ann Thorac Surg. 2015 Aug; 100(2):535-41.
    View in: PubMed
    Score: 0.008
  24. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients. Ann Thorac Surg. 2014 Jun; 97(6):2097-103.
    View in: PubMed
    Score: 0.007
  25. Survival in elderly patients supported with continuous flow left ventricular assist device as bridge to transplantation or destination therapy. J Card Fail. 2014 Mar; 20(3):161-7.
    View in: PubMed
    Score: 0.007
  26. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant. 2009 Apr; 28(4):352-9.
    View in: PubMed
    Score: 0.005
  27. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009 Jan; 137(1):208-15.
    View in: PubMed
    Score: 0.005
  28. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg. 2008 Oct; 86(4):1227-34; discussion 1234-5.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.